Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.76x
ADVENZYMES's operating cash flow covered 76% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹1.09B
ADVENZYMES's free cash flow was ₹1.09B in FY 2025, up 9.7% from FY 2024.
Dividend Coverage
1.8x
ADVENZYMES's free cash flow covered dividends 1.8x in FY 2025 but leaves limited surplus.
CapEx Intensity
23.7%
Capital expenditure was 23.7% of operating cash flow in FY 2025 for ADVENZYMES, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 1.88B | 1.87B | |
| Cash flow Operating Activities | 1.41B | 1.42B | |
| Investments in PPE | -423.13M | -338.08M | |
| Cash flow Investing Activities | -646.49M | -891.01M | |
| Dividend Paid | -567.12M | -590.30M | |
| Cash flow Financing Activities | -592.38M | -725.44M | |
| Cash at beginning of period | 964.20M | 1.14B | |
| Cash at end of period | 1.14B | 942.25M | |
| Free Cash Flow | 990.56M | 1.09B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025